ESR1 and neoplasm: On the contrary, tumors of BRCA1 carriers were more aggressive than those of non‐BRCA breast cancer patients for all tumor characteristics examined (ER and PR status, grade, tumor size, nodal involvement and breast cancer subtype) except for the proportion of invasive tumors (eTable 7 in Data Supplement 1, Supporting Information).